{
"id":"mk19_bb_gm_s15",
"subspecialtyId":"gm",
"title":"Generalized Anxiety Disorder",
"jsonContent":{
"type":"section",
"id":"mk19_bb_gm_s15",
"title":{
"__html":"Generalized Anxiety Disorder"
},
"titleNode":{
"type":"section-title",
"hlId":"9e8536",
"children":[
"Generalized Anxiety Disorder"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_gm_s15_1",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"b490ad",
"children":[
"Generalized anxiety disorder is characterized by pervasive and excessive anxiety about a variety of events or activities, restlessness, difficulty concentrating, irritability, functional impairment, and sleep disturbance. Patients commonly have a comorbid psychiatric disorder."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_gm_s15_2",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"be56f0",
"children":[
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"cognitive behavioral therapy",
"children":[
"CBT"
]
},
","
]
},
" with or without pharmacologic therapy, is first-line treatment for generalized anxiety disorder. ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"selective serotonin reuptake inhibitor",
"children":[
"SSRI"
]
},
"s"
]
},
" and ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"serotonin-norepinephrine reuptake inhibitor",
"children":[
"SNRI"
]
},
"s"
]
},
" are effective. Benzodiazepines are acceptable for short-term use while titrating antidepressant doses, but dependence and tolerance complicate long-term use. Benzodiazepines should be avoided in patients with a history of substance use disorder."
]
}
]
}
]
},
"tablesContent":{
}
}